1. American Academy of Child and Adolescent Psychiatry (2011). Practice parameter on the use of atypical antipsychotic medications in children and adolescents. Available at: https://www.aacap.org/App_Themes/AACAP/docs/practice_parameters/Atypical_Antipsychotic_Medications_Web.pdf. Accessed Aug. 28 2021.
2. American Academy of Child and Adolescent Psychiatry (2009). Practice parameter for the assessment and treatment of children and adolescents with Oppositional Defiant Disorder. Available at: https://www.aacap.org/App_Themes/AACAP/docs/practice_parameters/Atypical_Antipsychotic_Medications_Web.pdf. Accessed Aug. 28 2021.
3. Aitken, M., Waxman, J. A., MacDonald, K., & Andrade, B. F. (2018). Effect of comorbid psychopathology and conduct problem severity on response to a multi-component intervention for childhood disruptive behavior. Child Psychiatry & Human Development, 49(6), 853–864. https://doi.org/10.1007/s10578-018-0800-1.
4. Allison, P. (1995). Survival analysis using the SAS System: A practical guide. The SAS Institute.
5. Bandou, N., Koike, K., & Matuura, H. (2010). Predictive familial risk factors and pharmacological responses in ADHD with comorbid disruptive behavior disorders: Pediatrics International, 52(3), 415–419. https://doi.org/10.1111/j.1442-200X.2009.03003.x.